TrialHaematologica2014
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.
Neha Korde et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it